MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
Beckman Research Institute
City of Hope, Estados UnidosBeckman Research Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Pembrolizumab in relapsed or refractory primary mediastinal large b-cell lymphoma
Journal of Clinical Oncology